Suppr超能文献

移植入人体心脏中的β-肾上腺素能受体:β-肾上腺素能受体密度未改变,但随着移植后时间的延长,β2-肾上腺素能受体的比例增加。

Beta-adrenoceptors in the transplanted human heart: unaltered beta-adrenoceptor density, but increased proportion of beta 2-adrenoceptors with increasing posttransplant time.

作者信息

Brodde O E, Khamssi M, Zerkowski H R

机构信息

Biochemisches Forschungslabor, Universitätsklinikum Essen, Federal Republic of Germany.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1991 Oct;344(4):430-6. doi: 10.1007/BF00172582.

Abstract

To study whether in the (denervated) transplanted human heart beta-adrenoceptors are up-regulated we determined in right ventricular endomyocardial biopsies (weighing 2-7 mg) of 8 heart transplant recipients beta-adrenoceptor density and beta 1:beta 2-adrenoceptor ratio in weekly, later monthly intervals for 6-18 posttransplant months. beta-adrenoceptor density was assessed by 1-2 concentration (-)-[125I]-iodocyanopindolol (ICYP, 200 and 150 pmol/l) binding, the beta 1:beta 2-adrenoceptor ratio by a beta 1-adrenoceptor saturating concentration of the selective beta 1-adrenoceptor antagonist CGP 20712 A (500 nmol/l). In biopsies taken from the donor hearts immediately before transplantation beta-adrenoceptor density was 64.5 +/- 6.3 fmol ICYP bound/mg protein (n = 5), the beta 1:beta 2-adrenoceptor ratio 81.2 +/- 2.2:18.8 +/- 2.2%. beta-Adrenoceptor density did not change during the whole period investigated; it was in the first 9 posttransplant weeks 73.1 +/- 8.3 (n = 22) and after 4-18 months 74.2 +/- 7.6 fmol/mg protein (n = 16). In contrast, with increasing posttransplant time beta 1:beta 2-adrenoceptor ratio was shifted towards beta 2-adrenoceptors: in the first 9 weeks it was 80:20% (n = 17), after 16 weeks 75:25% (n = 10) and after 25-80 weeks 65:35% (n = 7). We conclude that in the first 18 posttransplant months beta-adrenoceptors in the transplanted human heart are not up-regulated. There is, however, a gradual decline in beta 1- and increase in beta 2-adrenoceptors with increasing posttransplant time. As noradrenaline acts in the human heart solely at beta 1-adrenoceptors, while adrenaline activates both beta 1- and beta 2-adrenoceptors with about the same potency, with increasing posttransplant time (and increasing proportion of beta 2-adrenoceptors) adrenaline may play an important role for regulation of contractility and/or heart rate in heart transplant recipients.

摘要

为研究在(去神经支配的)移植人心脏中β-肾上腺素能受体是否上调,我们对8例心脏移植受者的右心室心内膜活检组织(重量为2 - 7毫克)进行了研究,在移植后6 - 18个月期间,每周、之后每月一次测定β-肾上腺素能受体密度以及β1:β2-肾上腺素能受体比例。通过1 - 2种浓度(-)-[125I]-碘氰吲哚洛尔(ICYP,200和150皮摩尔/升)结合来评估β-肾上腺素能受体密度,通过选择性β1-肾上腺素能受体拮抗剂CGP 20712 A(500纳摩尔/升)的β1-肾上腺素能受体饱和浓度来评估β1:β2-肾上腺素能受体比例。在移植前立即从供体心脏获取的活检组织中,β-肾上腺素能受体密度为64.5±6.3飞摩尔ICYP结合/毫克蛋白(n = 5),β1:β2-肾上腺素能受体比例为81.2±2.2:18.8±2.2%。在整个研究期间β-肾上腺素能受体密度没有变化;在移植后的前9周为73.1±8.3(n = 22),4 - 18个月后为74.2±7.6飞摩尔/毫克蛋白(n = 16)。相反,随着移植后时间的增加,β1:β2-肾上腺素能受体比例向β2-肾上腺素能受体偏移:在前9周为80:20%(n = 17),16周后为75:25%(n = 10),25 - 80周后为65:35%(n = 7)。我们得出结论,在移植后的前18个月,移植人心脏中的β-肾上腺素能受体没有上调。然而,随着移植后时间的增加,β1-肾上腺素能受体逐渐减少,β2-肾上腺素能受体逐渐增加。由于去甲肾上腺素在人心脏中仅作用于β1-肾上腺素能受体,而肾上腺素以大致相同的效力激活β1-和β2-肾上腺素能受体,随着移植后时间的增加(以及β2-肾上腺素能受体比例增加),肾上腺素可能在心脏移植受者的收缩力和/或心率调节中起重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验